Improved outcome of patients with mantle cell lymphoma (MCL) in first remission (CRI) after hematopoietic stem cell transplantation

被引：0
|
作者：
Kassim, A. [1 ]
Jagasia, M. [1 ]
Dixon, S. [1 ]
Chinratanalab, W. [1 ]
Morgan, D. [1 ]
Ruffner, K. [1 ]
Greer, J. [1 ]
Stein, R. [1 ]
Engelhardt, B. [1 ]
机构：
[1] Vanderbilt Univ, Nashville, TN 37235 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2007年 / 13卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2006.12.151
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
147
引用
收藏
页码：55 / 55
页数：1
相关论文
共 50 条
  • [21] Is hematopoietic cell transplantation still a valid option for mantle cell lymphoma in first remission in the chemoimmunotherapy-era?
    Chaudhary, L.
    Kharfan-Dabaja, M. A.
    Hari, P.
    Hamadani, M.
    BONE MARROW TRANSPLANTATION, 2013, 48 (12) : 1489 - 1496
  • [22] Is hematopoietic cell transplantation still a valid option for mantle cell lymphoma in first remission in the chemoimmunotherapy-era?
    L Chaudhary
    M A Kharfan-Dabaja
    P Hari
    M Hamadani
    Bone Marrow Transplantation, 2013, 48 : 1489 - 1496
  • [23] Tackling mantle cell lymphoma (MCL): Potential benefit of allogeneic stem cell transplantation
    Shanbhag, Satish
    Smith, Mitchell R.
    Emmons, Robert V. B.
    STEM CELLS AND CLONING-ADVANCES AND APPLICATIONS, 2010, 3 : 93 - 102
  • [24] Hematopoietic cell transplantation for mantle cell lymphoma
    Yanada, Masamitsu
    Yamamoto, Kazuhito
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2022, 115 (03) : 301 - 309
  • [25] Hematopoietic cell transplantation for mantle cell lymphoma
    Masamitsu Yanada
    Kazuhito Yamamoto
    International Journal of Hematology, 2022, 115 : 301 - 309
  • [26] Correction to: Impact of hematopoietic stem cell transplantation in patients with relapsed or refractory mantle cell lymphoma
    Satoshi Yamasaki
    Dai Chihara
    Sung-Won Kim
    Koji Izutsu
    Kouji Iwato
    Takahiro Fukuda
    Naoyuki Uchida
    Itsuto Amano
    Hideyuki Nakazawa
    Junya Kuroda
    Hisako Hashimoto
    Tatsuo Ichinohe
    Yoshinobu Kanda
    Yoshiko Atsuta
    Junji Suzumiya
    Ritsuro Suzuki
    Annals of Hematology, 2018, 97 : 2013 - 2014
  • [27] Allogeneic Hematopoietic Stem Cell Transplantation in Mantle Cell Lymphoma: A Retrospective Analysis of 7 Patients
    Lamm, Wolfgang
    Wohlfarth, Philipp
    Bojic, Marija
    Schoergenhofer, Christian
    Kalhs, Peter
    Raderer, Markus
    Rabitsch, Werner
    ONCOLOGY, 2015, 89 (02) : 118 - 123
  • [28] Improved outcome of adult T cell leukemia/lymphoma with allogeneic hematopoietic stem cell transplantation
    A Utsunomiya
    Y Miyazaki
    Y Takatsuka
    S Hanada
    K Uozumi
    S Yashiki
    M Tara
    F Kawano
    Y Saburi
    H Kikuchi
    M Hara
    H Sao
    Y Morishima
    Y Kodera
    S Sonoda
    M Tomonaga
    Bone Marrow Transplantation, 2001, 27 : 15 - 20
  • [29] Improved outcome of adult T cell leukemia/lymphoma with allogeneic hematopoietic stem cell transplantation
    Utsunomiya, A
    Miyazaki, Y
    Takatsuka, Y
    Hanada, S
    Uozumi, K
    Yashiki, S
    Tara, M
    Kawano, F
    Saburi, Y
    Kikuchi, H
    Hara, M
    Sao, H
    Morishima, Y
    Kodera, Y
    Sonoda, S
    Tomonaga, M
    BONE MARROW TRANSPLANTATION, 2001, 27 (01) : 15 - 20
  • [30] Rituximab Containing Autologous Stem Cell Transplantation May Be Curative in Mantle Cell Lymphoma for Patients in First Remission, but Not for Patients with Recurrent Disease
    Tam, Constantine S.
    Bassett, Roland
    Ledesma, Celina
    Korbling, Martin J.
    Okoroji, Grace-Julia
    Harrell, Robyn
    Hsu, Yvonne
    Silva, Leandro De Padua
    Alousi, Amin M.
    Hosing, Chitra M.
    Kebriael, Partow
    Rondon, Gabriela
    Giralt, Sergio
    De Lima, Marcos
    Anderlini, Paolo
    Popat, Uday
    Qazilbash, Muzaffar H.
    Samuels, Barry
    Champlin, Richard E.
    Khouri, Issa F.
    BLOOD, 2008, 112 (11) : 417 - 417
12345